Terms: = Liver cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
44 results:
1. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
Zhang H; Wang J; Yang M
Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
[TBL] [Abstract] [Full Text] [Related]
2. Is the anterior approach recommended for liver resection of hepatocellular carcinoma? A systematic review and meta-analysis.
Ishii T; Iwaki K; Nakakura A; Uchida Y; Ito T; Hatano E
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):133-142. PubMed ID: 37984829
[TBL] [Abstract] [Full Text] [Related]
3. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1.
Liao J; Chen Z; Chang R; Yuan T; Li G; Zhu C; Wen J; Wei Y; Huang Z; Ding Z; Chu L; Liang J; Zhang B
Int J Biol Sci; 2023; 19(16):5218-5232. PubMed ID: 37928273
[TBL] [Abstract] [Full Text] [Related]
4. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract] [Full Text] [Related]
5. New Evidence of Oral Branched-Chain Amino Acid Supplementation on the prognosis of Patients With Advanced liver Disease.
Lee H; Yoo JJ; Ahn SH; Kim BK
Clin Transl Gastroenterol; 2022 Dec; 13(12):e00542. PubMed ID: 36250703
[TBL] [Abstract] [Full Text] [Related]
6. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
7. Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis.
Kim TH; Jung YK; Yim HJ; Baik JW; Yim SY; Lee YS; Seo YS; Kim JH; Yeon JE; Byun KS
Clin Mol Hepatol; 2022 Oct; 28(4):876-889. PubMed ID: 36117443
[TBL] [Abstract] [Full Text] [Related]
8. Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway.
Xie H; Jing R; Liao X; Chen H; Xie X; Dai H; Pan L
Hereditas; 2022 Jul; 159(1):29. PubMed ID: 35836300
[TBL] [Abstract] [Full Text] [Related]
9. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
[TBL] [Abstract] [Full Text] [Related]
10. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract] [Full Text] [Related]
11. The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.
Ke Q; Xin F; Fang H; Zeng Y; Wang L; Liu J
Front Immunol; 2022; 13():913464. PubMed ID: 35677059
[TBL] [Abstract] [Full Text] [Related]
12. RNA Helicase DHX37 Facilitates liver cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1.
Liu Z; Ye Y; Liu Y; Liu Y; Chen H; Shen M; Wang Z; Huang S; Han L; Chen Z; He X
Cancer Res; 2022 May; 82(10):1937-1952. PubMed ID: 35290436
[TBL] [Abstract] [Full Text] [Related]
13. ZC3H15 Correlates with a Poor prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract] [Full Text] [Related]
14. Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
Valenciaga A; Iwenofu OH; Tinoco G
J Natl Compr Canc Netw; 2021 Jul; 19(7):775-779. PubMed ID: 34340207
[TBL] [Abstract] [Full Text] [Related]
15. Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Ren Z; Xu J; Bai Y; Xu A; Cang S; Du C; Li Q; Lu Y; Chen Y; Guo Y; Chen Z; Liu B; Jia W; Wu J; Wang J; Shao G; Zhang B; Shan Y; Meng Z; Wu J; Gu S; Yang W; Liu C; Shi X; Gao Z; Yin T; Cui J; Huang M; Xing B; Mao Y; Teng G; Qin Y; Wang J; Xia F; Yin G; Yang Y; Chen M; Wang Y; Zhou H; Fan J;
Lancet Oncol; 2021 Jul; 22(7):977-990. PubMed ID: 34143971
[TBL] [Abstract] [Full Text] [Related]
16. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
[TBL] [Abstract] [Full Text] [Related]
17. Identification of Key Genes for Hepatitis Delta Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhang C; Wu S; Yang XD; Xu H; Ma T; Zhu QX
Turk J Gastroenterol; 2021 Feb; 32(2):169-177. PubMed ID: 33960941
[TBL] [Abstract] [Full Text] [Related]
18. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
[TBL] [Abstract] [Full Text] [Related]
19. Is left-sided involvement of hepatocellular carcinoma an important preoperative predictive factor of poor outcome?
Sakuraoka Y; Kubota K; Tanaka G; Shimizu T; Tago K; Park KH; Matsumoto T; Shiraki T; Mori S; Iso Y; Aoki T
World J Surg Oncol; 2020 Dec; 18(1):317. PubMed ID: 33272298
[TBL] [Abstract] [Full Text] [Related]
20. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract] [Full Text] [Related]
[Next]